دورية أكاديمية
A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma
| العنوان: | A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma |
|---|---|
| المؤلفون: | Esteban J. Rozen, Kim Wigglesworth, Jason M. Shohet |
| المصدر: | Biomedicines, Vol 12, Iss 1, p 197 (2024) |
| بيانات النشر: | MDPI AG, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Biology (General) |
| مصطلحات موضوعية: | DYRK3, CAMKV, neuroblastoma, cell proliferation, mitotic spindle, biomolecular condensates, Biology (General), QH301-705.5 |
| الوصف: | High-risk neuroblastoma is a very aggressive pediatric cancer, accounting for ~15% of childhood cancer mortality. Therefore, novel therapeutic strategies for the treatment of neuroblastoma are urgently sought. Here, we focused on the potential implications of the Dual-specificity tYrosine-Regulated Kinase (DYRK) family and downstream signaling pathways. We used bioinformatic analysis of public datasets from neuroblastoma cohorts and cell lines to search correlations between patient survival and expression of DYRK kinases. Additionally, we performed biochemical, molecular, and cellular approaches to validate and characterize our observations, as well as an in vivo orthotopic murine model of neuroblastoma. We identified the DYRK3 kinase as a critical mediator of neuroblastoma cell proliferation and in vivo tumor growth. DYRK3 has recently emerged as a key regulator of several biomolecular condensates and has been linked to the hypoxic response of neuroblastoma cells. Our data suggest a role for DYRK3 as a regulator of the neuroblastoma-specific protein CAMKV, which is also required for neuroblastoma cell proliferation. CAMKV is a very understudied member of the Ca2+/calmodulin-dependent protein kinase family, originally described as a pseudokinase. We show that CAMKV is phosphorylated by DYRK3, and that inhibition of DYRK3 kinase activity induces CAMKV aggregation, probably mediated by its highly disordered C-terminal half. Importantly, we provide evidence that the DYRK3/CAMKV signaling module could play an important role for the function of the mitotic spindle during cell division. Our data strongly support the idea that inhibition of DYRK3 and/or CAMKV in neuroblastoma cells could constitute an innovative and highly specific intervention to fight against this dreadful cancer. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 12010197 2227-9059 |
| Relation: | https://www.mdpi.com/2227-9059/12/1/197; https://doaj.org/toc/2227-9059 |
| DOI: | 10.3390/biomedicines12010197 |
| URL الوصول: | https://doaj.org/article/0ee963b66a144d33ba4c76f4b0b2dd62 |
| رقم الأكسشن: | edsdoj.0ee963b66a144d33ba4c76f4b0b2dd62 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 12010197 22279059 |
|---|---|
| DOI: | 10.3390/biomedicines12010197 |